SCHEMBL8677705

SCHEMBL8677705

O=Cc1cccc2ncc(-c3ccccc3)nc12

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.45
PARP1 P09874 4/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
PDGFRB P09619 1/20 0.44
KDR P35968 1/20 0.44
FLT3 P36888 1/20 0.44
PARP2 Q9UGN5 1/20 0.42
BCHE P06276 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
NOS1 P29475 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9885994 0.77 MET (0.54) TLR9PARP1NPC1RAB9ASMN1; SMN2
SCHEMBL9203841 0.76 PARP1 (0.54) PARP1NPC1RAB9AALDH1A1
SCHEMBL28221938 0.76 NPC1 (0.60) TLR9PARP1NPC1RAB9ASMN1; SMN2
SCHEMBL13019019 0.76 NPC1 (0.53) TLR9PARP1NPC1RAB9ASMN1; SMN2
SCHEMBL31353303 0.76 RAB9A (0.47) TLR9PARP1NPC1RAB9ASMN1; SMN2
SCHEMBL20212713 0.76 ALDH1A1 (0.38) NPC1RAB9AALDH1A1GAA
SCHEMBL1034874 0.75 PARP1 (0.62) PARP1SMN1; SMN2PARP2BCHEALDH1A1
SCHEMBL9409728 0.75 PARP1 (0.48) PARP1NPC1RAB9ASMN1; SMN2PDGFRB
SCHEMBL31353202 0.73 PARP1 (0.59) PARP1NPC1RAB9ASMN1; SMN2PDGFRB
SCHEMBL7111338 0.73 PARP1 (0.80) PARP1PARP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5721248-A CALCIUM AGONISTS; TREATING CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-02-24 US disclosed
US-5545646-A CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1996-08-13 US disclosed
EP-0630895-A1 4-Bicyclic substituted dihydropyridines, process for their preparation and their use in medicaments BAYER AG (DE) 1994-12-28 EP disclosed